Incretins and SGLT-2i Therapy of Type 2 Diabetes – Real Life Study of Their Therapeutic and Economic Effects

AIM: Incretins [dipeptidyl peptidase-4 inhibitors (DPP-4i) and glucagon-like peptide 1 RA (GLP-1 RA)] and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) groups are now routinely used for type 2 diabetes therapy and comprise a large number of medicinal products. The long term therapeutic and eco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitkova, Zornitsa, Mitov, Konstantin, Valov, Vasil, Manova, Manoela, Savova, Alexandra, Kamusheva, Maria, Tcharaktchiev, Dimitar, Angelov, Zhivko, Angelova, Galia, Petrova, Guenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477021/
https://www.ncbi.nlm.nih.gov/pubmed/31040779
http://dx.doi.org/10.3389/fphar.2019.00364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477021/
https://www.ncbi.nlm.nih.gov/pubmed/31040779
http://dx.doi.org/10.3389/fphar.2019.00364

Ejemplares similares